ARMS-PCR
CTCs
ER+ breast cancer
ESR1
NAME-Pro
cell free DNA
circulating tumour DNA
liquid biopsy
mutation analysis
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
01 Feb 2021
01 Feb 2021
Historique:
received:
02
12
2020
revised:
15
01
2021
accepted:
26
01
2021
entrez:
4
2
2021
pubmed:
5
2
2021
medline:
5
2
2021
Statut:
epublish
Résumé
A considerable number of estrogen receptor-positive breast cancer (ER
Identifiants
pubmed: 33535614
pii: cancers13030556
doi: 10.3390/cancers13030556
pmc: PMC7867152
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Stavros Niarchos Foundation
ID : grant number 16785
Organisme : NCI NIH HHS
ID : R33 CA217652
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA221874
Pays : United States
Références
Clin Cancer Res. 2017 Jan 1;23(1):88-96
pubmed: 27334837
Cancer Cell. 2017 Feb 13;31(2):172-179
pubmed: 28196593
Breast Cancer Res Treat. 2017 Dec;166(3):695-700
pubmed: 28815327
Matrix Biol. 2015 Apr;43:42-60
pubmed: 25728938
Breast Cancer Res Treat. 2016 Jun;157(2):253-265
pubmed: 27178332
Curr Treat Options Oncol. 2019 Jun 29;20(8):68
pubmed: 31256282
Expert Rev Mol Diagn. 2019 Jul;19(7):599-611
pubmed: 31188645
Nat Med. 2008 May;14(5):579-84
pubmed: 18408729
Cancer Res. 2018 Feb 15;78(4):1110-1122
pubmed: 29233927
BMC Cancer. 2011 Oct 04;11:422
pubmed: 21967632
Oncotarget. 2016 Nov 15;7(46):74448-74459
pubmed: 27801670
Oncol Lett. 2019 Sep;18(3):2771-2776
pubmed: 31452755
JCO Precis Oncol. 2019 May 21;3:
pubmed: 32914015
Cancers (Basel). 2019 Nov 28;11(12):
pubmed: 31795152
Oncotarget. 2018 Aug 3;9(60):31606-31619
pubmed: 30167082
Transl Res. 2015 Dec;166(6):540-553.e2
pubmed: 26434753
Genome Res. 2019 Sep;29(9):1429-1441
pubmed: 31362937
N Engl J Med. 2018 Nov 15;379(20):1926-1936
pubmed: 30345905
J Clin Oncol. 2016 Sep 1;34(25):2961-8
pubmed: 27269946
Cancer Discov. 2016 May;6(5):479-91
pubmed: 26969689
F1000Res. 2016 Jun 17;5:1411
pubmed: 27703666
Clin Cancer Res. 2016 Mar 1;22(5):1130-7
pubmed: 26500237
Clin Cancer Res. 2017 Mar 1;23(5):1126-1131
pubmed: 27979914
Nat Rev Cancer. 2019 Oct;19(10):553-567
pubmed: 31455893
Cancer Discov. 2018 Nov;8(11):1390-1403
pubmed: 30206110
Nat Genet. 2013 Dec;45(12):1439-45
pubmed: 24185512
Cancer Discov. 2018 Oct;8(10):1286-1299
pubmed: 30104333
J Mol Diagn. 2020 Jan;22(1):111-121
pubmed: 31669227
Cancer Treat Res Commun. 2019;19:100123
pubmed: 30826563
Clin Chem. 2011 Aug;57(8):1169-77
pubmed: 21700955
Ann Oncol. 2018 Jan 1;29(1):145-153
pubmed: 29045530
Clin Chem. 2009 Apr;55(4):632-40
pubmed: 19201784
Breast Cancer Res. 2018 May 16;20(1):40
pubmed: 29769099
Oncogene. 2020 Apr;39(14):2987-2995
pubmed: 32042112
J Mol Diagn. 2010 Sep;12(5):697-704
pubmed: 20616362
PLoS One. 2013 Sep 18;8(9):e75038
pubmed: 24058649
Clin Cancer Res. 2014 Apr 1;20(7):1757-1767
pubmed: 24398047
Clin Cancer Res. 2014 Nov 15;20(22):5823-34
pubmed: 25398847
Breast Cancer Res Treat. 2017 Jun;163(2):231-240
pubmed: 28283903
Clin Cancer Res. 2018 Feb 1;24(3):560-568
pubmed: 29180605
Clin Cancer Res. 2018 Mar 15;24(6):1500-1510
pubmed: 29284708
Nucleic Acids Res. 2016 Nov 2;44(19):e146
pubmed: 27431322
Nat Commun. 2018 Mar 1;9(1):896
pubmed: 29497091
Expert Rev Mol Diagn. 2013 Nov;13(8):827-44
pubmed: 24127721
Clin Cancer Res. 2017 Oct 15;23(20):6086-6093
pubmed: 28679775
Anal Chem. 2019 Oct 15;91(20):13105-13111
pubmed: 31538770
Mol Oncol. 2019 Dec;13(12):2515-2530
pubmed: 31254443
Crit Rev Clin Lab Sci. 2014 Jun;51(3):160-71
pubmed: 24641350
Clin Chem. 2015 Jan;61(1):112-23
pubmed: 25388429
Clin Chem. 2011 Mar;57(3):421-30
pubmed: 21245367
Mol Oncol. 2018 Jan;12(1):48-57
pubmed: 29063679
Clin Chem. 2011 Jan;57(1):136-8
pubmed: 20974797